Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
ESMO Open|December 6, 2019
Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trialsManuel Benavides, Eduardo Díaz-Rubio, Alfredo Carrato, et al.
Human Psychopharmacology|July 8, 2017
Biomarkers of the alcohol hangover state: Ethyl glucuronide (EtG) and ethyl sulfate (EtS)Marlou Mackus, Aurora J A E van de Loo, S Jorinde Raasveld, et al.
European Urology Focus|July 30, 2017
Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell CancerEnrique González-Billalabeitia, Juan Manuel Sepúlveda, Pablo Maroto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2021
Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)Manuel Benavides, Auxiliadora Gómez-España, Pilar García-Alfonso, et al.
European Journal of Clinical Investigation|August 1, 2025
Circulating hsa-miR-29c-3p and VEGF-A levels predict the response to FOLFIRI plus aflibercept in elderly metastatic colorectal cancer patientsMarta Toledano-Fonseca, María Teresa Cano-Osuna, Elena Élez, et al.
Nature Communications|June 28, 2019
Insights into real-time chemical processes in a calcium sensor protein-directed dynamic libraryAndrea Canal-Martín, Javier Sastre, María José Sánchez-Barrena, et al.
Drugs & Aging|February 22, 2021
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled AnalysisPilar García-Alfonso, Eduardo Díaz-Rubio, Albert Abad, et al.
Clinical Colorectal Cancer|April 13, 2020
Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively CollectedJavier Sastre, Virginia de la Orden, Antonio Martínez, et al.
The Lancet. Gastroenterology & Hepatology|January 19, 2020
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 studyPhilip A Philip, Jill Lacy, Fabienne Portales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B StudyJoana Vidal, Maria Concepción Fernández-Rodríguez, David Casadevall, et al.
Pageof 15